Anzeige
Mehr »
Donnerstag, 14.05.2026 - Börsentäglich über 12.000 News

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
ACCESS Newswire
513 Leser
Artikel bewerten:
(2)

Flo Health Publishes Groundbreaking Research on Economic Impact of Digital Tools for Endometriosis Care

Peer-reviewed study finds Flo Health's Symptom Checker could deliver nearly $10,100 in net monetary benefit per patient while cutting diagnosis wait time in half

NEW YORK CITY, NY / ACCESS Newswire / March 3, 2026 / Flo Health, the world's #1 women's health app, today announced publication of the first-ever economic evaluation of a digital symptom checker for endometriosis, underscoring the significant financial and health benefits that digital health technology can deliver to women navigating one of the most under-recognized conditions in gynecologic care.

The study, titled "Economic evaluation of a digital symptom checker for endometriosis using a Markov decision process model," and published in npj Digital Medicine, a top peer-reviewed journal in the Nature Portfolio, was conducted in partnership with researchers from The London School of Hygiene & Tropical Medicine and the York Health Economic Consortium. It examined the health and economic outcomes of using Flo Health's Symptom Checker alongside standard care, compared to standard care alone.

Despite affecting approximately 190 million women globally, endometriosis carries an average diagnostic delay of seven years, during which women frequently experience severe menstrual cramps, chronic pelvic pain, and pain during intercourse while receiving insufficient guidance. This delay is associated with increased disease severity, worsening pain, and more complex treatment paths.

The research produced the following key findings:

  • Women using Flo Health's Symptom Checker alongside standard care received diagnoses in approximately 3 years, compared to the 7-year average under standard care alone, a reduction of more than 50%

  • Patients gained nearly three weeks of additional healthy life, as measured by quality-adjusted life years (QALYs)

  • The tool generated approximately $5,196 USD in savings per person over 40 years through reduced medical costs and productivity gains

  • The total net monetary benefit per patient reached $10,089 USD, based on a willingness-to-pay threshold of $100,000 per QALY, a common benchmark for U.S. institutional payers

"When women are empowered to take control of their health, the benefits go beyond early diagnoses to overall improved physical and emotional well-being," said Dr. Anna Klepchukova, Chief Medical Officer at Flo Health. "This research explores how digital tools may help women better recognize their symptoms and bring clearer insights into conversations with their health care providers."

Flo Health's Symptom Checker is designed as an educational resource that helps users identify symptom patterns that may be consistent with endometriosis, prompting earlier engagement with health care providers. The tool is not intended to diagnose, treat, or replace professional medical care. More than 2.7 million women in the United States have used Flo Health's Symptom Tracker for endometriosis-related support.

Researchers also noted that digital symptom checkers provide the greatest value when tool accuracy exceeds 70%, user compliance surpasses 45%, and outcomes are measured over a minimum 10-year time horizon. The authors indicate that the economic modeling framework applied in this study could be replicated to evaluate digital health tools targeting other conditions that disproportionately affect women and face similar barriers to timely diagnosis.

The publication adds to a growing body of evidence supporting Flo Health's mission to build a better future for female health through trusted, data-backed digital tools. Flo Health currently supports 77 million monthly active users and collaborates with more than 100 medical experts worldwide.

About Flo Health

Flo Health is the leading app in the Health & Fitness category and the #1 OB-GYN-recommended app for period and cycle tracking. As the first European femtech unicorn following a General Atlantic investment in July 2024, Flo Health supports 77 million monthly active users with curated cycle and ovulation tracking, tailored health insights, and a private community for women at every stage of life. Through its Pass it on Project, Flo Health has donated 20 million Premium subscriptions toward its goal of providing 1 billion women in need with free access to health information. For more information, visit flo.health.

PR Contact
Samantha Wannemacher
Flo Health
s_wannemacher@flo.health

SOURCE: Flo Health



View the original press release on ACCESS Newswire:
https://www.accessnewswire.com/newsroom/en/healthcare-and-pharmaceutical/flo-health-publishes-groundbreaking-research-on-economic-impact-of-di-1143443

© 2026 ACCESS Newswire
Vergessen Sie Gold, Silber und Öl: Nächste Megarallye startet!
Die Märkte feiern neue Rekorde – doch im Hintergrund braut sich eine Entwicklung zusammen, die alles verändern könnte. Die anhaltende Sperrung der Straße von Hormus sorgt laut IEA für eine der größten Energiekrisen aller Zeiten. Gleichzeitig schießen die Preise für Düngemittel und Agrarrohstoffe bereits nach oben.

Damit droht ein perfekter Sturm: steigende Energiepreise, explodierende Produktionskosten und ein möglicher Super-El-Nino, der weltweit Ernten gefährdet. Erste Auswirkungen sind längst sichtbar – Weizen, Soja und Kakao verteuern sich deutlich, während Lebensmittelpreise vor dem nächsten Sprung stehen könnten.

Für Anleger bedeutet das nicht nur Risiken, sondern enorme Chancen. Denn während klassische Märkte unter Druck geraten könnten, entsteht auf den Feldern und Plantagen der nächste große Rohstoffzyklus. Wer sich jetzt richtig positioniert, kann von einer Entwicklung profitieren, die weit über Öl und Metalle hinausgeht.

In unserem aktuellen Spezialreport stellen wir drei Aktien vor, die besonders aussichtsreich sind, um von diesem Trend zu profitieren – solide positioniert, strategisch relevant und mit erheblichem Aufwärtspotenzial.



Jetzt den kostenlosen Report sichern – bevor der Agrar-Boom voll durchschlägt!
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.